HuGE Literature Finder
|
||
Records 1-69
|
Is primary sidedness a prognostic factor in patients with resected colon cancer liver metastases (CLM)?
Journal of surgical oncology 2018 Apr . Marques Márcio C, C Ribeiro Héber S, Costa Wílson L, de Jesus Victor Hugo F, de Macedo Mariana P, Diniz Alessandro L, Godoy André L, Farias Igor C, Aguiar Samuel, Riechelmann Rachel S P, S Begnami Maria Dirlei F, Coimbra Felipe J |
|
KRAS and 2 rare PI3KCA mutations coexisting in a metastatic colorectal cancer patient with aggressive and resistant disease.
Human pathology 2018 Apr 74 178-182. Tessitore Alessandra, Bruera Gemma, Mastroiaco Valentina, Cannita Katia, Cortellini Alessio, Cocciolone Valentina, Dal Mas Antonella, Calvisi Giuseppe, Zazzeroni Francesca, Ficorella Corrado, Ricevuto Enrico, Alesse Edoar |
|
Podoplanin-positive cancer-associated fibroblast recruitment within cancer stroma is associated with a higher number of single nucleotide variants in cancer cells in lung adenocarcinoma.
Journal of cancer research and clinical oncology 2018 Mar . Nakasone Shoko, Mimaki Sachiyo, Ichikawa Tomohiro, Aokage Keiju, Miyoshi Tomohiro, Sugano Masato, Kojima Motohiro, Fujii Satoshi, Kuwata Takeshi, Ochiai Atsushi, Tsuboi Masahiro, Goto Koichi, Tsuchihara Katsuya, Ishii Genichi |
|
<i>BRAF</i> and <i>RAS</i> mutational status in non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive subtype of encapsulated follicular variant of papillary thyroid carcinoma in Korea.
Thyroid : official journal of the American Thyroid Association 2018 Feb . Kim Mijin, Jeon MinJi, Oh Hye-Seon, Park Suyeon, Kim Tae Yong, Shong YoungKee, Kim Won Bae, Kim Kyunggon, Kim Won Gu, Song Dong E |
|
Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).
BMC cancer 2018 01 18 (1): 11. Huemer Florian, Thaler Josef, Piringer Gudrun, Hackl Hubert, Pleyer Lisa, Hufnagl Clemens, Weiss Lukas, Greil Richa |
|
Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and TRIBE trials.
Annals of oncology : official journal of the European Society for Medical Oncology 2017 Nov 28 (11): 2780-2785. Berger M D, Stintzing S, Heinemann V, Yang D, Cao S, Sunakawa Y, Ning Y, Matsusaka S, Okazaki S, Miyamoto Y, Suenaga M, Schirripa M, Soni S, Zhang W, Falcone A, Loupakis F, Lenz H |
|
Clinicopathological characteristics of thyroid cancer in the federal state of Salzburg.
Wiener klinische Wochenschrift 2017 May . Rendl Gundula, Rodrigues Margarida, Schweighofer-Zwink Gregor, Hutter Josef, Hittmair Anton, Zellinger Barbara, Hauser-Kronberger Cornelia, Pirich Christi |
|
Risk factors for brain metastases in patients with metastatic colorectal cancer.
Acta oncologica (Stockholm, Sweden) 2017 May 56 (5): 639-645. Christensen Troels Dreier, Palshof Jesper Andreas, Larsen Finn Ole, Høgdall Estrid, Poulsen Tim Svenstrup, Pfeiffer Per, Jensen Benny Vittrup, Yilmaz Mette Karen, Christensen Ib Jarle, Nielsen Dor |
|
Mitochondrial DNA alteration in primary and metastatic colorectal cancer: Different frequency and association with selected clinicopathological and molecular markers.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017 Mar 39 (3): 1010428317692246. Kleist Britta, Meurer Thuja, Poetsch Micae |
|
Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and Prognosis of Colorectal Cancer Patients.
Pathology oncology research : POR 2017 Feb . Jin Mei, Long Zi-Wen, Yang Jing, Lin Xia |
|
KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2017 Feb . Sullivan I, Salazar J, Arqueros C, Andrés M, Sebio A, Majem M, Szafranska J, Martínez E, Páez D, López-Pousa A, Baiget M, Barnadas |
|
Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients.
BMC cancer 2017 01 17 (1): 38. Nakayama Izuma, Shinozaki Eiji, Matsushima Tomohiro, Wakatsuki Takeru, Ogura Mariko, Ichimura Takashi, Ozaka Masato, Takahari Daisuke, Suenaga Mitsukuni, Chin Keisho, Mizunuma Nobuyuki, Yamaguchi Kens |
|
Frequent Coamplification of Receptor Tyrosine Kinase and Downstream Signaling Genes in Japanese Primary Gastric Cancer and Conversion in Matched Lymph Node Metastasis.
Annals of surgery 2016 Oct . Silva Arnaldo N S, Coffa Jordy, Menon Varsha, Hewitt Lindsay C, Das Kakoli, Miyagi Yohei, Bottomley Dan, Slaney Hayley, Aoyama Toru, Mueller Wolfram, Arai Tomio, Tan Iain B, Deng Niantao, Chan Xiu B, Tan Patrick, Tsuburaya Akira, Sakamaki Kentaro, Hayden Jeremy D, Yoshikawa Takaki, Zondervan Ilse, Savola Suvi, Grabsch Heike |
|
High prevalence of concomitant oncogene mutations in prospectively identified patients with ROS1-positive metastatic lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Aug . Wiesweg Marcel, Eberhardt Wilfried E E, Reis Henning, Ting Saskia, Savvidou Nikoleta, Skiba Charlotte, Herold Thomas, Christoph Daniel C, Meiler Johannes, Worm Karl, Kasper Stefan, Theegarten Dirk, Hense Jörg, Hager Thomas, Darwiche Kaid, Oezkan Filiz, Aigner Clemens, Welter Stefan, Kühl Hilmar, Stuschke Martin, Schmid Kurt W, Schuler Mart |
|
Impact of 3'UTR variation patterns of the KRAS gene on the aggressiveness of pancreatobiliary tumors with the KRAS G13D mutation in a Turkish population.
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2016 May . Egeli Unal, Ak Secil, Cecener Gulsah, Tunca Berrin, Tezcan Gulcin, Sevinc Elif Demirdogen, Kaya Ekrem, Dundar Halit Ziya, Sarkut Pinar, Ozen Yilmaz, Balcin Ozkan, Evrensel Turkkan, Yerci Omer, Ugras Nesr |
|
[Mutation status of epidermal growth factor receptor and KRAS gene in non-small cell lung cancers at Xuanwei regions of Yunnan Province].
Zhonghua bing li xue za zhi Chinese journal of pathology 2016 Apr 45 (4): 226-30. Yang C S, Pan X Y, Feng Q, Wang Y Y, Xu W M, Jiang T, Wang L, Yang J L, Wang |
|
Morphological and molecular approach to synchronous non-small cell lung carcinomas: impact on staging.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Apr . Schneider Frank, Derrick Veronica, Davison Jon M, Strollo Diane, Incharoen Pimpin, Dacic San |
|
Detection of PIK3CA mutations, including a novel mutation of V344G in exon 4, in metastatic lung adenocarcinomas: A retrospective study of 115 FNA cases.
Cancer cytopathology 2016 Mar . Allison Derek B, Lilo Mohammed T, Geddes Susan, Pallavajjalla Aparna, Askin Frederic, Gabrielson Edward, Zheng Gang, Li Qing K |
|
Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Oncotarget 2016 Mar 7 (12): 14095-111. Kim Jung Ho, Bae Jeong Mo, Cho Nam-Yun, Kang Gyeong Ho |
|
Medullary carcinoma in the colorectum: a systematic review and meta-analysis.
Human pathology 2016 Mar . Pyo Jung-Soo, Sohn Jin Hee, Kang Guhy |
|
Sensitive methods for screening of the MEK1 gene mutations in patients with central nervous system metastases of non-small cell lung cancer.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2016 Feb . Nico? M, Krawczyk P, Jarosz B, Sawicki M, Michnar M, Trojanowski T, Milanowski |
|
Distribution of KRAS and BRAF Mutations in Metastatic Colorectal Cancers in Turkish Patients.
Asian Pacific journal of cancer prevention : APJCP 2016 17 (3): 1175-9. Gorukmez Orhan, Yakut Tahsin, Gorukmez Ozlem, Sag Sebnem Ozemri, Karkucak Mutlu, Kanat Ozk |
|
KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy.
Annals of surgical oncology 2016 08 23 (8): 2548-55. Chow Oliver S, Kuk Deborah, Keskin Metin, Smith J Joshua, Camacho Niedzica, Pelossof Raphael, Chen Chin-Tung, Chen Zhenbin, Avila Karin, Weiser Martin R, Berger Michael F, Patil Sujata, Bergsland Emily, Garcia-Aguilar Jul |
|
Mutation Analysis of KRAS and BRAF Genes in Metastatic Colorectal Cancer: a First Large Scale Study from Iran.
Asian Pacific journal of cancer prevention : APJCP 2016 17 (2): 603-8. Koochak Aghigh, Rakhshani Nasser, Karbalaie Niya Mohammad Hadi, Tameshkel Fahimeh Safarnezhad, Sohrabi Masoud Reza, Babaee Mohammad Reza, Rezvani Hamid, Bahar Babak, Imanzade Farid, Zamani Farhad, Khonsari Mohammad Reza, Ajdarkosh Hossein, Hemmasi Gholamre |
|
Prognostic relevance of autophagy-related markers LC3, p62/sequestosome 1, Beclin-1 and ULK1 in colorectal cancer patients with respect to KRAS mutational status.
World journal of surgical oncology 2016 14 (1): 189. Schmitz Klaus Juergen, Ademi Ceflije, Bertram Stefanie, Kurt Werner Schmid, Baba Hideo Andre |
|
Value of KRAS, BRAF, and PIK3CA Mutations and Survival Benefit from Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis.
Asian Pacific journal of cancer prevention : APJCP 2016 17 (2): 539-43. Sasaki Yusuke, Hamaguchi Tetsuya, Yamada Yasuhide, Takahashi Naoki, Shoji Hirokazu, Honma Yoshitaka, Iwasa Satoru, Okita Natsuko, Takashima Atsuo, Kato Ken, Nagai Yushi, Taniguchi Hirokazu, Boku Narikazu, Ushijima Toshikazu, Shimada Yasuhi |
|
Relationship Between 18F-FDG PET/CT Scans and KRAS Mutations in Metastatic Colorectal Cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2015 Sep 56 (9): 1322-7. Kawada Kenji, Toda Kosuke, Nakamoto Yuji, Iwamoto Masayoshi, Hatano Etsuro, Chen Fengshi, Hasegawa Suguru, Togashi Kaori, Date Hiroshi, Uemoto Shinji, Sakai Yoshiha |
|
Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancers.
Human pathology 2015 Jul . Koelzer Viktor Hendrik, Huber Bettina, Mele Valentina, Iezzi Giandomenica, Trippel Mafalda, Karamitopoulou Eva, Zlobec Inti, Lugli Alessand |
|
Identification of KRAS and PIK3CA but not BRAF mutations in patients with gastric cancer.
Molecular medicine reports 2015 Jul 12 (1): 1219-24. Lu Weipeng, Wei Hong, Li Mei, Wang Hai, Liu Lina, Zhang Qiuping, Liu Lisha, Lu Sh |
|
MicroRNA-224 is associated with colorectal cancer progression and response to 5-fluorouracil-based chemotherapy by KRAS-dependent and -independent mechanisms.
British journal of cancer 2015 Apr 112 (9): 1480-90. Amankwatia E B, Chakravarty P, Carey F A, Weidlich S, Steele R J C, Munro A J, Wolf C R, Smith |
|
Prognostic impact of KRAS mutation subtypes in 677 patients with metastatic lung adenocarcinomas.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2015 Mar 10 (3): 431-7. Yu Helena A, Sima Camelia S, Shen Ronglai, Kass Samantha, Gainor Justin, Shaw Alice, Hames Megan, Iams Wade, Aston Jonathan, Lovly Christine M, Horn Leora, Lydon Christine, Oxnard Geoffrey R, Kris Mark G, Ladanyi Marc, Riely Gregory |
|
Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages.
BMC cancer 2015 15 (1): 340. Li Wenbin, Qiu Tian, Zhi Wenxue, Shi Susheng, Zou Shuangmei, Ling Yun, Shan Ling, Ying Jianming, Lu Ni |
|
Correlation between activation of PI3K/AKT/mTOR pathway and prognosis of breast cancer in Chinese women.
PloS one 2015 10 (3): e0120511. Deng Ling, Chen Jie, Zhong Xiao Rong, Luo Ting, Wang Yan Ping, Huang Hui Fen, Yin Li-Juan, Qiu Yan, Bu Hong, Lv Qing, Zheng Ho |
|
Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil.
Oncology 2015 89 (3): 175-86. de Melo Andreia Cristina, Karen de Sá Vanessa, Sternberg Cinthya, Olivieri Eloisa Ribeiro, Werneck da Cunha Isabela, Fabro Alexandre Todorovic, Carraro Dirce Maria, de Barros E Silva Milton José, Pimenta Inada Haynna Kimie, de Mello Evandro Sobrosa, Soares Fernando Augusto, Takagaki Tereza, Ferreira Carlos Gil, Capelozzi Vera Lui |
|
Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets.
Annals of surgical oncology 2014 Nov 21 (12): 3827-34. Zhu Andrew X, Borger Darrell R, Kim Yuhree, Cosgrove David, Ejaz Aslam, Alexandrescu Sorin, Groeschl Ryan Thomas, Deshpande Vikram, Lindberg James M, Ferrone Cristina, Sempoux Christine, Yau Thomas, Poon Ronnie, Popescu Irinel, Bauer Todd W, Gamblin T Clark, Gigot Jean Francois, Anders Robert A, Pawlik Timothy |
|
Clinicopathology and genetic profile of synchronous multiple small adenocarcinomas: implication for surgical treatment of an uncommon lung malignancy.
Annals of surgical oncology 2014 Aug 21 (8): 2555-62. Lin Mong-Wei, Wu Chen-Tu, Kuo Shuenn-Wen, Chang Yih-Leong, Yang Pan-Ch |
|
Implication of K-ras and p53 in colorectal cancer carcinogenesis in Tunisian population cohort.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Jul 35 (7): 7163-75. Ines Chaar, Donia Ounissi, Rahma Boughriba, Ben Ammar Azza, Sameh Amara, Khalfallah Taher, Abdelmajid Ben Hmida, Sabeh Mzabi, Saadia Bourao |
|
Frequency, characterization, and prognostic analysis of PIK3CA gene mutations in Chinese esophageal squamous cell carcinoma.
Human pathology 2014 Feb 45 (2): 352-8. Hou Jun, Jiang Dongxian, Zhang Jingchuan, Gavine Paul R, Xu Songtao, Liu Yalan, Xu Chen, Huang Jie, Tan Yunshan, Wang Hao, Lu Yachao, Zheng Li, Hou Yingyong, Tan Lij |
|
Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
International journal of clinical and experimental pathology 2014 7 (9): 5927-39. Kleist Britta, Kempa Marcel, Novy Michael, Oberkanins Christian, Xu Li, Li Guojun, Loland Christiane, Poetsch Micae |
|
The KRAS-variant and miRNA expression in RTOG endometrial cancer clinical trials 9708 and 9905.
PloS one 2014 9 (4): e94167. Lee Larissa J, Ratner Elena, Uduman Mohamed, Winter Kathryn, Boeke Marta, Greven Kathryn M, King Stephanie, Burke Thomas W, Underhill Kelly, Kim Harold, Boulware Raleigh J, Yu Herbert, Parkash Vinita, Lu Lingeng, Gaffney David, Dicker Adam P, Weidhaas Joan |
|
The relationship between KRAS gene mutations and HLA class I antigen downregulation in the metastasis of non-small cell lung cancer.
The Journal of international medical research 2013 Oct 41 (5): 1473-83. He Xiao-Peng, Song Fu-Jie, Liu Xiang-Yan, Wang Zhou, Li Xiang-Xin, Liu Fan-Ying, Chen Gang, Jiang Wen-Pe |
|
Endometrial carcinomas with significant mucinous differentiation associated with higher frequency of k-ras mutations: a morphologic and molecular correlation study.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2013 Sep 23 (7): 1231-6. Xiong Jinjun, He Mai, Jackson Cynthia, Ou Joyce J, Sung C James, Breese Virgina, Steinhoff Margaret M, Quddus M Ruhul, Tejada-Berges Trevor, Lawrence W Dway |
|
CHFR aberrant methylation involves a subset of human lung adenocarcinoma associated with poor clinical outcomes.
Human pathology 2013 Jul 44 (7): 1382-90. Koga Takaomi, Takeshita Masafumi, Ijichi Kayo, Yano Tokujiro, Maehara Yoshihiko, Sueishi Kats |
|
Methylation levels of LINE-1 in primary lesion and matched metastatic lesions of colorectal cancer.
British journal of cancer 2013 Jul 109 (2): 408-15. Murata A, Baba Y, Watanabe M, Shigaki H, Miyake K, Ishimoto T, Iwatsuki M, Iwagami S, Sakamoto Y, Miyamoto Y, Yoshida N, Nosho K, Baba |
|
Somatic mutation profiling and associations with prognosis and trastuzumab benefit in early breast cancer.
Journal of the National Cancer Institute 2013 Jul 105 (13): 960-7. Loi Sherene, Michiels Stefan, Lambrechts Diether, Fumagalli Debora, Claes Bart, Kellokumpu-Lehtinen Pirkko-Liisa, Bono Petri, Kataja Vesa, Piccart Martine J, Joensuu Heikki, Sotiriou Christ |
|
Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Jun 34 (3): 1901-11. Malhotra Pooja, Anwar Mumtaz, Nanda Neha, Kochhar Rakesh, Wig Jai Dev, Vaiphei Kim, Mahmood Safr |
|
Mutation analysis of KRAS in primary colorectal cancer and matched metastases by means of highly sensitivity molecular assay.
Pathology, research and practice 2013 Apr 209 (4): 233-6. Miglio Umberto, Mezzapelle Rosanna, Paganotti Alessia, Allegrini Sara, Veggiani Claudia, Antona Jlenia, Gentilli Sergio, Monga Guido, Alabiso Oscar, Boldorini Ren |
|
The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
Annals of surgical oncology 2013 Apr 20 (4): 1395-402. Takatsuno Yasushi, Mimori Koshi, Yamamoto Ken, Sato Tetsuya, Niida Atsushi, Inoue Hiroshi, Imoto Seiya, Kawano Shuhei, Yamaguchi Rui, Toh Hiroyuki, Iinuma Hisae, Ishimaru Shinya, Ishii Hideshi, Suzuki Sadao, Tokudome Shinkan, Watanabe Masahiko, Tanaka Jun-Ichi, Kudo Shin-Ei, Mochizuki Hidetaka, Kusunoki Masato, Yamada Kazutaka, Shimada Yasuhiro, Moriya Yoshihiro, Miyano Satoru, Sugihara Kenichi, Mori Masa |
|
Significance of HPV infection and genic mutation of APC and K-ras in patients with rectal cancer.
Asian Pacific journal of cancer prevention : APJCP 2013 14 (1): 121-6. Sun Zhen-Qiang, Wang Hai-Jiang, Zhao Ze-Liang, Wang Qi-San, Fan Chuan-Wen, Fang |
|
KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue.
International journal of cancer. Journal international du cancer 2012 Dec . Mostert B, Jiang Y, Sieuwerts AM, Wang H, Vries JB, Biermann K, Kraan J, Lalmahomed Z, van Galen A, de Weerd V, van der Spoel P, Ramírez-Moreno R, Verhoef C, Ijzermans JN, Wang Y, Gratama JW, Foekens JA, Sleijfer S, Martens JW |
|
KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer.
British journal of cancer 2012 Dec 107 (12): 1997-2004. Birkeland E, Wik E, Mjøs S, Hoivik E A, Trovik J, Werner H M J, Kusonmano K, Petersen K, Raeder M B, Holst F, Øyan A M, Kalland K-H, Akslen L A, Simon R, Krakstad C, Salvesen H |
|
Ploidy and S-phase fraction are correlated with lymphovascular space invasion that is predictive of outcomes in endometrial cancer.
International journal of clinical oncology 2012 Dec 17 (6): 590-7. Song Taejong, Lee Jeong-Won, Choi Chel Hun, Kim Tae-Joong, Bae Duk-Soo, Sung Chang Ohk, Song Sang Yong, Kim Byoung-G |
|
Concordant KRAS Mutations in Primary and Metastatic Colorectal Cancer Tissue Specimens: A Meta-Analysis and Systematic Review.
Cancer investigation 2012 Oct . Han CB, Li F, Ma JT, Zou HW |
|
[Correlation of KRAS gene mutations and clinicopathologic parameters in colorectal carcinoma].
Zhonghua bing li xue za zhi Chinese journal of pathology 2012 Sep 41 (9): 9. Wang Q, Zhong M, Lü YL, Yuan J, Wei LX |
|
Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancer.
Clinical colorectal cancer 2012 Mar 11 (1): 53-9. Carneiro Benedito A, Ramanathan Ramesh K, Fakih Marwan G, Krishnamurthi Smitha S, Lembersky Barry C, Stoller Ronald G, Lancaster Stewart L, Pinkerton Richard A, Crandall Theodore L, Schmotzer Amy R, Potter Douglas M, Bahary Nath |
|
Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma.
BMC cancer 2012 12 (1): 416. Suda Toshihito, Hama Takanori, Kondo Shu, Yuza Yuki, Yoshikawa Mamoru, Urashima Mitsuyoshi, Kato Takakuni, Moriyama Hiros |
|
Detection of KRAS mutations and their associations with clinicopathological features and survival in Chinese colorectal cancer patients.
The Journal of international medical research 2012 40 (4): 1589-98. Li Z, Chen Y, Wang D, Wang G, He L, Suo |
|
Multigene mutation analysis of metastatic lymph nodes in non-small cell lung cancer diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration.
Chest 2011 Nov 140 (5): 1319-24. Nakajima Takahiro, Yasufuku Kazuhiro, Nakagawara Akira, Kimura Hideki, Yoshino Ichi |
|
The status of EGFR-associated genes could predict the outcome and tumor response of chemo-refractory metastatic colorectal patients using cetuximab and chemotherapy.
Journal of surgical oncology 2011 Nov 104 (6): 661-6. Lin Jen-Kou, Lin An-Jen, Lin Chun-Chi, Lan Yuan-Tzu, Yang Shung-Haur, Li Anna Fen-Yau, Chang Shih-Chi |
|
Clinical characterization of patients with metastatic colorectal cancer depending on the KRAS status.
Anti-cancer drugs 2011 Oct 22 (9): 913-8. Modest Dominik P, Stintzing Sebastian, Laubender Ruediger P, Neumann Jens, Jung Andreas, Giessen Clemens, Haas Michael, Aubele Philipp, Schulz Christoph, Boeck Stefan, Stemmler Hans-Joachim, Kirchner Thomas, Heinemann Volk |
|
Correlation of genes associated with drug response to prognosis of large cell lung carcinoma.
Chinese journal of cancer 2011 Jul 30 (7): 497-504. Chen Cheng, Jiang Xiang-Li, Zhang Cui-Cui, Li K |
|
Evaluation of Kras Gene Mutation and Copy Number Gain in Non-small Cell Lung Cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011 Jan 6 (1): 1. Sasaki H, Hikosaka Y, Kawano O, Moriyama S, Yano M, Fujii Y |
|
Comparison of KRAS and EGFR gene status between primary non-small cell lung cancer and local lymph node metastases: implications for clinical practice.
Journal of experimental & clinical cancer research : CR 2011 30 (1): 30. Sun Leina, Zhang Qiang, Luan Huanling, Zhan Zhongli, Wang Changli, Sun Baoc |
|
KRAS mutation in metastatic pancreatic ductal adenocarcinoma: results of a multicenter phase II study evaluating efficacy of cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line therapy.
Oncology 2011 81 (1): 3-8. Kullmann F, Hartmann A, Stöhr R, Messmann H, Dollinger M M, Trojan J, Fuchs M, Hollerbach S, Harder J, Troppmann M, Kutscheidt A, Endlicher |
|
Screening for EGFR and KRAS mutations in endobronchial ultrasound derived transbronchial needle aspirates in non-small cell lung cancer using COLD-PCR.
PloS one 2011 6 (9): e25191. Santis George, Angell Roger, Nickless Guillermina, Quinn Alison, Herbert Amanda, Cane Paul, Spicer James, Breen Ronan, McLean Emma, Tobal Khal |
|
Cetuximab as second-line therapy in patients with metastatic esophageal adenocarcinoma: a phase II Southwest Oncology Group Study (S0415).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010 Sep 5 (9): 1472-6. Gold Philip J, Goldman Bryan, Iqbal Syma, Leichman Lawrence P, Zhang Wu, Lenz Heinz-Josef, Blanke Charles |
|
Multiple genetic alterations in papillary thyroid cancer are associated with younger age at presentation.
The Journal of surgical research 2010 May 160 (2): 179-83. Moses Willieford, Weng Julie, Khanafshar Elham, Duh Quan-Yang, Clark Orlo H, Kebebew Electr |
|
EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Jul 15 (14): 14. Schmid K, Oehl N, Wrba F, Pirker R, Pirker C, Filipits M |
|
Fast simultaneous detection of K-RAS mutations in colorectal cancer.
BMC cancer 2009 9 (1): 179. Chang Ya-Sian, Yeh Kun-Tu, Chang Tien-Jye, Chai Connie, Lu Hsiu-Chin, Hsu Nicholas C, Chang Jan-Gow |
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 15, 2019
- Content source: